These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27662562)

  • 1. Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
    Bigenwald C; Harel S; Chevignon F; Roos-Weil D; Bernard OA; Amorim S; Brice P; Adès L; Nloga AM; Sébert M; Braun T; Eclache V; Thieblemont C; Fenaux P
    Br J Haematol; 2018 Jan; 180(2):304-308. PubMed ID: 27662562
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma.
    Reiss J; Link B; Ruan J; Furman R; Coleman M; Leonard J; Martin P
    Leuk Lymphoma; 2015; 56(10):2870-5. PubMed ID: 25676037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Sill H
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
    de Graeff A; Vendrik CP; Pinedo HM
    Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
    Thakral B; Muzzafar T
    Blood; 2017 Jul; 130(2):231. PubMed ID: 28705862
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy-related myelodysplastic syndrome (t-MDS)].
    Yoshida Y
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):206-8. PubMed ID: 9851122
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndrome in a child with a history of medulloblastoma.
    Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
    Shih AH; Chung SS; Dolezal EK; Zhang SJ; Abdel-Wahab OI; Park CY; Nimer SD; Levine RL; Klimek VM
    Haematologica; 2013 Jun; 98(6):908-12. PubMed ID: 23349305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 14. Empty marrow following previous irradiation in a patient with therapy-related myelodysplastic syndrome.
    Lee CH; Chen TY
    Br J Haematol; 2017 Dec; 179(5):703. PubMed ID: 28857127
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
    de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
    Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.
    Sasaki K; Jabbour E; Cortes J; Kadia T; Garcia-Manero G; Borthakur G; Jain P; Pierce S; Daver N; Takahashi K; O'Brien S; Kantarjian H; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):616-624. PubMed ID: 27601000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterogeneity of leukemia occurring after treatment for sarcoma.
    Varterasian M; Zalupski M; Karanes C
    Am J Clin Oncol; 1997 Dec; 20(6):585-6. PubMed ID: 9391546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.
    Sevcikova K; Zhuang Z; Garcia-Manero G; Alvarez RH; Kantarjian HM; Mego M; Albarracin C; Tang G; Strom SS; Medeiros LJ; Hortobagyi GN; Reuben JM; Khoury JD
    Leukemia; 2016 Jan; 30(1):242-7. PubMed ID: 25975189
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related myelodysplastic syndrome in adults with neurofibromatosis.
    Papageorgio C; Seiter K; Feldman EJ
    Leuk Lymphoma; 1999 Feb; 32(5-6):605-8. PubMed ID: 10048435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
    Epperla N; Pham AQ; Burnette BL; Wiseman GA; Habermann TM; Macon WR; Ansell SM; Inwards DJ; Micallef IN; Johnston PB; Markovic SN; Porrata LF; Colgan JP; Ristow KM; Nowakowski GS; Witzig TE
    Br J Haematol; 2017 Aug; 178(3):427-433. PubMed ID: 28466487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.